Home Newsfeeds Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44

Barclays Maintains Equal-Weight on Pfizer, Lowers Price Target to $44

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $50 to $44.

byBenzinga Newsdesk

October 12, 2022

1 minute read

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and lowers the price target from $50 to $44.

BMO Capital Maintains Market Perform on Gatos Silver, Raises Price Target to $3.75

By Benzinga Newsdesk

October 4, 7:21 AM

BMO Capital analyst Ryan Thompson maintains Gatos Silver (NYSE:GATO) with a Market Perform and raises the price target from $3.25 to $3.75.

GATO

What’s Going On With Alibaba Stock Friday?

By Anusuya Lahiri

January 26, 8:39 AM

Alibaba's stock drops amid US-China tensions and legislative challenges to Chinese biotech firms. In contrast, Alibaba's innovation in AI with its new AI PPT tool by Quark shows a promising advance in practical AI applications, marking a strategic shift in Chinese tech capabilities.

BABA

Nike Q1 Earnings Highlights: Revenue And EPS Beat, Investors Pull Back On Inventory, China Concerns

By Chris Katje

September 29, 4:34 PM

Apparel and footwear company Nike Inc (NYSE: NKE) reported first-quarter financial results after market close Thursday. Here are the key highlights for Nike investors.

NKE